期刊文献+

266例下呼吸道感染肺炎克雷伯杆菌的耐药性分析 被引量:2

下载PDF
导出
摘要 目的:了解常州市第一人民医院呼吸科住院患者中下呼吸道感染者肺炎克雷伯杆菌的耐药性情况。方法:收集2009年1月~2012年12月住院患者中下呼吸道感染者行痰培养且结果显示为肺炎克雷伯杆菌266株,采用琼脂稀释法进行药敏试验,依据标准进行结果判读。结果:本组患者中,肺炎克雷伯杆菌占较高比例;肺炎克雷伯杆菌对碳青霉烯类抗生素(亚胺培南、美洛培南)总体耐药率仍较低,但已经出现耐药性,耐药率有逐年升高趋势;肺炎克雷伯杆菌对氨基糖苷类药物中的阿米卡星耐药率较低,4年来保持较低且稳定的耐药率,而对庆大霉素耐药率较高,并且耐药率有上升趋势;肺炎克雷伯杆菌对喹诺酮类(左旋氧氟沙星、环丙沙星)保持较高的耐药率,且耐药率总体呈上升趋势;肺炎克雷伯杆菌对β-内酰胺类抗生素的耐药率较高,呈上升趋势。结论:本院肺炎克雷伯杆菌感染率较高,耐药率高,并呈现多重耐药;应加强临床使用抗菌药物的管理,做到合理应用抗菌药,预防和减少菌株的耐药性。
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第7期980-982,共3页 Journal of Nanjing Medical University(Natural Sciences)
  • 相关文献

参考文献4

  • 1汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2009,9(5):321-329. 被引量:422
  • 2National Committee for Clinical Laboratory Standards. Per- formance standards for antimicrobial susceptibility testing IS]. 19th informational supplement. M100-S19 Pennsylva- nia: CLSI, 2009: 67-84.
  • 3Keynan Y, Rubinstein E. The changing face of Klebsiella pneumoniae infections in the community[J]. Int J An- timicrob Agents, 2007,30(5 ) : 385.
  • 4朱亚萍,刘荣玉.肺炎克雷伯杆菌耐碳青霉烯类的机制及其防治[J].国际呼吸杂志,2011,31(2):125-128. 被引量:4

二级参考文献30

  • 1王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 2Clinical and I.aboratory Standards Institute(CLSI). Perform ance standards for Antimicrobial susceptibility testing[S]. M100-S17, 2007.
  • 3Clinical and Laboratory Standards Institute (CLSI). Perform anee standards for Antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 4Bratu S, I.andman D, Haag R, et al. Rapid spread of carbapenem resistant Klebsiella pneumoniae in New York City: anew threat to our antibiotic armamentarium[J]. Arch Int Meal.2005,165(12) :1430-1435.
  • 5Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA [J]. J Antimierob Chemother, 2009, 63(3):427-437.
  • 6Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem resistant Acinetobacter baumannii producing the OXA- 23 β- lactamase in Korea[J]. J Clin Microbiol, 2005, 43(5):2241 -2245.
  • 7NaasT, LevyM, HirschauerC, et al. Outbreak ofcarbapen em resistant Acinetobacter baumannii producing the carbap enemase OXA- 23 in a tertiary care hospital of Pepcete, French Polynesta[J]. J Clin Mierohiol, 2005, 43 (9) : 4826- 4829.
  • 8Waites KB, Dully LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and invitro activity of tigecycline, a new glycylcycline antimicrobial[J]. Antimicrob Agents Chemother, 2006,50(10):3479- 3484.
  • 9Souli M, Kontopidou FV, Koratzanis E, et al. lnvitro activity of tigecycline against multiple-drug resistant, including pan resistant, Gram negative and Gram-positive clinical isolates from Greek hospitals[J]. Antimicrob Agents Chemother, 2006.50(9) :3166- 3169.
  • 10Gordon NC, Warehan, DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline [J]. J Antimicrob Chemother, 2009, 63(4) :775-780.

共引文献424

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部